Biological validation of ELM and ELM-2 in the cardiovascular cohort.
- Helene Skjøt-Arkil (425174)
- Rikke E. Clausen (425175)
- Lars M. Rasmussen (425176)
- Wanchun Wang (425177)
- Yaguo Wang (425178)
- Qinlong Zheng (344473)
- Hans Mickley (425179)
- Lotte Saaby (425180)
- Axel C. P. Diederichsen (425181)
- Jess Lambrechtsen (425182)
- Fernando J. Martinez (49907)
- Cory M. Hogaboam (197986)
- MeiLan Han (425183)
- Martin R. Larsen (375762)
- Arkadiusz Nawrocki (344466)
- Ben Vainer (344474)
- Dorrit Krustrup (425184)
- Marina Bjørling-Poulsen (425185)
- Morten A. Karsdal (197639)
- Diana J. Leeming (287061)
Publication date
June 2013
DOIAbstract
<p>Human serum from patients with acute myocardial infarction (AMI) (n = 30), non-AMI (n = 30), coronary calcium shown on CT scans (CT-plusCA)(n = 30) and no coronary calcium detectable on a CT scan (n = 30). Bars indicate mean level. Groups were compared by Wilcoxon rank sum test. A)ELM-2, B) ELM and C) The Spearman correlation between ELM and ELM-2. Data are shown as mean±SD with 95% confidence intervals. ** p<0.01.</p
Add to ORKG